The list of blood pressure medications under recall notice has expanded once again.
On Thursday, Torrent Pharmaceuticals Limited told the Food and Drug Administration (FDA) it was recalling an additional 36 lots of its Losartan Potassium Tablets USP and an additional 68 lots of Losartan Potassium/hydrochlorothiazide tablets USP.
The company said it was expanding the recall to “the consumer level” because of the discovery of trace amounts of an impurity found in an active pharmaceutical ingredient.
This was the fourth recall since December of blood pressure medications manufactured by Torrent Pharmaceuticals.
It’s also the latest in a long line of blood pressure medications that have been recalled since late July due to the detection in the products of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), which has been classified as a potential cancer-causing substance.